| Today's Open | $35.78 |
|---|---|
| Previous Close | $35.75 |
| Daily Range | $35.50 - $36.20 |
| 52-Week Range | $19.03 - $39.00 |
| Market Cap | $4.3B |
| P/E Ratio | -72.96 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 450,242 |
| Average Daily Volume | 818,731 |
| Current FY EPS | -$0.82 |
Sector
Healthcare
Industry
Drugs
Seattle Genetics, Inc. (SGEN) Description
A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seagen.com/
News & Commentary
Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B
Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIATackling Cancer: Leukemia's Biggest Current and Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.SGEN's Top Competitors
(-0.06%)
(2.02%)
(1.31%)
(2.73%)